Table 2.

Dengue diagnostic practices among primary care physicians

	Overall		P value	Private practice		P value	Polyclinic practice		P value
	2011 N = 364 (%)	2014 N = 293 (%)		2011 N = 253 (%)	2014 N = 206 (%)		2011 N = 105 (%)	2014 N = 87 (%)
WHO warning signs
Yes	285 (78.3)	250 (85.3)	0.024	N.A.	171 (83.4)	N.A.	N.A.	79 (91.9)	N.A.
D.N.P.	3 (0.8)	2 (0.7)			2 (1)			1 (1.1)
Dengue Diagnostic Test (DDT)
Always (100%)	107 (29.4)	164 (56.0)	<0.001	98 (38.7)	111 (53.9)	0.001	7 (6.7)	53 (60.9)	<0.001
Often (51–99%)	69 (19.0)	72 (24.5)	0.086	51 (20.2)	52 (25.2)	0.216	17 (16.2)	20 (23.0)	0.274
Sometimes (1–50%)	105 (28.8)	40 (13.7)	<0.001	61 (24.1)	26 (12.6)	0.002	41 (39)	14 (16.1)	<0.001
Never (0%)	82 (22.5)	17 (5.8)	<0.001	43 (17.0)	17 (8.3)	0.008	39 (37.1)	0	<0.001
D.N.P.	1 (0.3)	0		0	0		1 (1)	0
Dengue Diagnostic Test (DDT)
> 50% of the time	176 (48.4)	236 (80.5)	<0.001	149 (58.9)	163 (79.1)	<0.001	24 (22.9)	73 (83.9)	<0.001
D.N.P.	1 (0.3)	0		0	0		1 (1)	0
Most Frequently Used DDT Among Those Who Reported Usage of DDT
Dengue serology (IgM/IgG)	211 (74.8)	91 (33)	<0.001	144 (68.6)	59 (31.2)	<0.001	62 (93.9)	32 (36.8)	<0.001
Dengue non-structural antigen 1 (NS1) assay	31 (11)	62 (22.5)	<0.001	29 (13.8)	47 (24.9)	0.003	1 (1.5)	15 (17.2)	0.002
Dengue RT-PCR	37 (13.1)	9 (3.3)	<0.001	36 (17.1)	7 (3.7)	<0.001	1 (1.5)	2 (2.3)	>0.999
Dengue duo POCT kit	0 (0.0)	104 (37.7)	<0.001	0	67 (35.4)	<0.001	0	37 (42.5)	<0.001
D.N.P.	3 (1.1)	10 (3.5)		1 (0.5)	9 (4.8)		2 (3)	1 (1.2)

D.N.P. Data not provided by participants, RT-PCR Reverse-transcription polymerase chain reaction, N.A. Not available

P value in bold represents a statistical significant difference